Propranolol for infantile hemangiomas: promise, peril, pathogenesis.
Department of Dermatology and Pediatrics, University of California San Francisco, San Francisco, California, USA.
Ilona J
IJ
Frieden
Beth A
BA
Drolet
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006391:Hemangioma / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007223:Infant; D011433:Propranolol / Q000627:therapeutic use*; D019043:Vascular Neoplasms / Q000188:drug therapy* / Q000209:etiology
D000319:Adrenergic beta-Antagonists; D011433:Propranolol